Distinguished in Low Blood Sugar

Guillaume Charpentier

Evry, FR 
Distinguished in Low Blood Sugar
Evry, FR 
OverviewLocationsClinical Research

Overview

Guillaume Charpentier practices in Evry, France. Mr. Charpentier is rated as a Distinguished expert by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Low Blood Sugar, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Islet Cell Transplantation.

His clinical research consists of co-authoring 97 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 18 articles in the study of Low Blood Sugar.

Gender
Male

Locations

Evry, 91042, France
Other Locations
Corbeil-essonnes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Validation of a Predictive Risk Equation for Type 2 Diabetes in Children With Diabetes to Achieve a Predictive Diagnostic Biochip for the Early Detection of Individuals at Risk in Families.
Enrollment Status: Completed
Publish Date: May 11, 2021
Intervention Type: Other
Study Phase: Not Applicable
Multicentre Randomized Cross-over Study Assessing in Type 1 Diabetic Patients With Pump Insulin the Non-inferiority of Glycemic Control Obtained With the Algorithms Tested in DIABRASPORT Versus the Rest Period Without Physical Activity
Multicentre Randomized Cross-over Study Assessing in Type 1 Diabetic Patients With Pump Insulin the Non-inferiority of Glycemic Control Obtained With the Algorithms Tested in DIABRASPORT Versus the Rest Period Without Physical Activity
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Device, Behavioral
Study Phase: Not Applicable
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen
Enrollment Status: Completed
Publish Date: August 21, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

96 Total Publications

Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trial.
Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trial.
Journal: Diabetes & metabolism
Published: May 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Charpentier's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile